Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug launch
Pharma
Zevra CEO drafts big ambitions for Miplyffa's US adoption curve
With Miplyffa, Zevra's CEO wants to transform the American treatment landscape for Niemann-Pick disease type C into one resembling Europe’s.
Fraiser Kansteiner
Jun 3, 2026 11:17am
Manufacturing hurdles stifle launches as biologics gain steam
May 15, 2026 9:20am
Gilead says long-acting PrEP Yeztugo in line for $1B in '26 sales
May 8, 2026 11:30am
Pre-launch efforts linked to lasting drug awareness edge: report
May 8, 2026 4:52am
Novo's Wegovy pill debuts with $355M in Q1
May 6, 2026 11:21am
Lilly stands behind strength of early Foundayo launch
Apr 30, 2026 11:42am
